Mylan

Weak sterling boosts FTSE as markets elsewhere await US Fed decision

Markets report: Aryzta continues slide in Dublin; Bank of Ireland, Ryanair fall

Pfizer and Mylan to combine off-patent drugs businesses

Deal between makers of EpiPens and Viagra will create group with global annual revenues worth €18bn

Pfizer expected to announce stock deal with Mylan

Deal would cover former blockbuster brands like Lipitor and Viagra, both made in Ireland

European shares end lower as Fed optimism short-lived

Markets report: Airbus rises after strong delivery numbers, Superdry slumps to a loss

European shares drop on growth and trade concerns

Dalata and Ryanair both lost ground, while Irish banking stocks were in favour

Business This Week: results, indicators and meetings

Ibec to host its European election debates and IFG shareholders vote on takeover

Indivior shares tank after US indictment for illegal marketing

Shares in British maker of opioid addiction treatment Suboxone fell more than 70%

All eyes on loan growth as Bank of Ireland reports full-year results

This Week: Big week for banks as SME lending stays weak amid Brexit caution

State fails to save millions on HSE medicines bill

Lobbyists call for extending use of cheaper ‘copycat’ drugs where available

This Week in Business: Blair to address Web Summit Lisbon

National Analytics Conference takes place in Dublin, results due from Liberty Media

HSE may miss out on €37m savings as costly drug Humira comes off patent

Policy of switching to biosimilar drugs never adopted

Ryanair lobbies on tax, Tyrone firm urges staff to get Irish passports and what next for the NBP?

Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk

Mylan claims HSE could save €42m with use of biosimilar drug for arthritis

Company plans to introduce generic version of Humira either later this year or early in 2019

European shares dip amid ongoing trade tensions

Markets report: Iseq down almost 0.8% as Aryzta hits fresh low

Mylan says US healthcare market is ‘unsustainable’

Generic drugs giant falls far short of Wall Street forecasts with second-quarter profit

This Week: Results from KBC, Glanbia and Kerry Group

Figures for car sales in July to give pointer to performance for remainder of year

Rural broadband plan looks offline, Brexit strategy shambles and Love Island

Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk

Mylan urges Government to boost take-up of biosimilars

Drugmaker says approving more biosimilar drugs for use here could save the State €140m a year

Drug patent protection regime needs to change

The public can’t continue to pay for the inaction of policymakers

European court decision may lead to more affordable access to HIV drug

Biopharma firm Gilead unsuccessful in patent row over its pre-exposure prophylaxis drug

Banking culture fails customers, Mylan’s HIV self-test kit, and Aeroflot’s budget airline set for Dublin

Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk

Mylan to launch HIV self-test kit in the Irish market

Kit allows patients test for HIV from home, with results coming 15 minutes after testing

HSE could save up to €140m on medicines, says industry group

Spending on high-tech drugs almost doubles to over €660m in nine years

Pharma body calls for more State funding on medicines

Government to save €15m this year as prices fall across 750 drugs

Court refuses injunctions in pharma patent case

Teva sought orders restraining Galway-based Mylan from making MS drug

Political nervousness in Spain and Italy impact on shares

Smurfit Kappa shares slide almost 7% while Aer Lingus owner IAG falls 3.49%

EU proposes waiver for manufacturers of generic drugs

Big pharma companies object to change that would allow generic manufacture of protected medicines for markets outside the bloc

Potential for 25,000 new pharma jobs, US-China trade deal, and Titanic tourism

Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk

Up to 25,000 pharma jobs if EU alters patent rules

Mylan boss calls for waiver on manufacturing of biosimilars

Start-up Nasal Medical signs distribution deal with Mylan

Company’s products will be distributed to more than 2,800 pharmacies

This week: Results from Walt Disney, News Corp and Horizon Pharma

Employment law conference to address ‘increasingly restrictive’ legislation

Bank of Ireland results and unemployment rate

Your upcoming week in business: retail sales and AIB results plus UK housing prices

Broad-based strengths

Barry McCall looks at some of the standout features of Ireland’s life sciences landscape

Two office blocks at Northern Cross for sale separately

Newenham House looking for €16.3m and Newenham Court seeks €9.15m

Gilead loss of generic HIV drug battle a boost for gay community

Generic versions of Truvada that are 60 per cent cheaper are about to hit Irish market

Teva sues Mylan Teoranta over alleged patent infringement

Mylan denies breaching patents

This Week: The events lined up in the business world

There’s the Web Summit in Lisbon, Portugal, plus results from Avis Budget and Trip Advisor

Mylan slashes earnings forecast on US generics price cuts

Earnings undershoot forecasts in second quarter despite acquisitions

Alliance of generic drug makers warns supply reforms needed

Group claims patients may face increasing difficulty accessing lifesaving medicines

Roche shares down after disappointing drug trial results

Pharma group’s breast cancer combination drug only slightly better than older medicine

YOU MAY ALSO LIKE...

Stardust

Inquests into the nightclub fire that led to the deaths of 48 people

Common Ground

How does a post-Brexit world shape the identity and relationship of these islands